Abstract
Rationale
In laboratory animals, the biological stressor yohimbine (α2-noradrenergic autoreceptor antagonist) promotes drug seeking. Human laboratory studies have demonstrated that psychological stressors can increase drug craving but not that stressors alter drug seeking.
Objectives
This clinical study tested whether yohimbine increases opioid-seeking behavior.
Methods
Ten heroin-dependent, buprenorphine-stabilized (8 mg/day) volunteers sampled two doses of hydromorphone [12 and 24 mg IM in counterbalanced order, labeled drug A (session 1) and drug B (session 2)]. During each of six later sessions (within-subject, double-blind, randomized crossover design), volunteers could respond on a 12-trial choice progressive ratio task to earn units (1 or 2 mg) of the sampled hydromorphone dose (drug A or B) vs money ($2) following different oral yohimbine pretreatment doses (0, 16.2, and 32.4 mg).
Results
Behavioral economic demand intensity and peak responding (O max) were significantly higher for hydromorphone 2 than 1 mg. Relative to placebo, yohimbine significantly increased hydromorphone demand inelasticity, more so for hydromorphone 1-mg units (P max = 909, 3,647, and 3,225 for placebo, 16.2, and 32.4 mg yohimbine doses, respectively) than hydromorphone 2-mg units (P max = 2,656, 3,193, and 3,615, respectively). Yohimbine produced significant but clinically modest dose-dependent increases in blood pressure (systolic ≈ 15 and diastolic ≈ 10 mmHg) and opioid withdrawal symptoms, and decreased opioid agonist symptoms and elated mood.
Conclusions
These findings concur with preclinical data by demonstrating that yohimbine increases drug seeking; in this study, these effects occurred without clinically significant subjective distress or elevated craving, and partly depended on opioid unit dose.
Similar content being viewed by others
References
Albus M, Zahn TP, Breier A (1992) Anxiogenic properties of yohimbine. I. Behaviour, physiological and biochemical measures. Eur Arch Psychiatry Clin Neurosci 241:337–344
Alexander BK, Coambs RB, Hadaway PF (1978) The effect of housing and gender on morphine self-administration in rats. Psychopharmacology 58:175–179
Banihashemi L, Rinaman L (2006) Noradrenergic inputs to the bed nucleus of the stria terminalis and paraventricular nucleus of the hypothalamus underlie hypothalamic-pituitary-adrenal axis but not hypophagic or conditioned avoidance responses to systemic yohimbine. J Neurosci 26:11442–11453
Banna KM, Back SE, Do P, See RE (2010) Yohimbine stress potentiates conditioned cue-induced reinstatement of heroin-seeking in rats. Behav Brain Res 208:144–148
Beardsley PM, Howard JL, Shelton KL, Carroll FI (2005) Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs. cocaine primes and its antidepressant-like effects in rats. Psychopharmacology (Berl) 183:118–126
Bickel WK, DeGrandpre RJ, Higgins ST (1993) Behavioral economics: a novel experimental approach to the study of drug dependence. Drug Alcohol Depend 33:173–192
Bozarth MA, Murray A, Wise RA (1989) Influence of housing conditions on the acquisition of intravenous heroin and cocaine self-administration in rats. Pharmacol Biochem Behav 33:903–907
Bradley BP, Phillips G, Green L, Gossop M (1989) Circumstances surrounding the initial lapse to opiate use following detoxification. Br J Psychiatry 154:354–359
Brown ZJ, Tribe E, D’souza NA, Erb S (2009) Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology 203:121–130
Buffalari DM, See RE (2011) Inactivation of the bed nucleus of the stria terminalis in an animal model of relapse: effects on conditioned cue-induced reinstatement and its enhancement by yohimbine. Psychopharmacology (Berl) 213:19–27
Buffalari DM, Baldwin CK, See RE (2012) Treatment of cocaine withdrawal anxiety with guanfacine: relationship to cocaine intake and reinstatement of cocaine seeking rats. Psychopharmacology (Berl) 223(2):179–190
Cameron OG, Zubieta JK, Grunhaus L, Minoshima S (2000) Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans. Psychosom Med 62:549–559
Carroll ME, Meisch RA (1984) Increased drug-reinforced behavior due to food deprivation. In: Thompson T, Barrett JE (eds) Advances in behavioral pharmacology, vol 4. Academic, New York, pp 47–88
Charney DS, Heninger GR, Redmond DE (1983) Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci 33:19–29
Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR (1992) Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatr Scand 86:273–282
Childs E, de Wit H (2010) Effects of acute psychological stress on cigarette craving and smoking. Nic Tob Res 4:449–453
Coffey SF, Stasiewicz PR, Hughes PM, Brimo ML (2006) Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav 20:425–435
de Wit H, Söderpalm AH, Nikolayev L, Young E (2003) Effects of acute social stress on alcohol consumption in healthy subjects. Alcohol Clin Exp Res 27:1270–1277
Doxey JC, Lane AC, Roach AG, Virdee NK (1984) Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine corynanthine. Naunyn Schmeidebergs Arch Pharmacol 325:136–144
Erb S, Hitchott PK, Rajabi H, Mueller D, Shaham Y, Stewart J (2000) Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23:138–150
Feltenstein MW, See RE (2006) Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine. Behav Brain Res 174:1–8
Feltenstein MW, Ghee SM, See RE (2012) Nicotine self-administration and reinstatement of nicotine-seeking in male and female rats. Drug Alcohol Depend 121:240–246
First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured Clinical Interview for DSM–IV Axis Disorders—Patient Edition (SCID-I/P, Version 2.0). New York State Psychiatric Institute, Biometrics Research Department, New York
Fox HC, Bergquist KL, Hoing KI, Sinha R (2007) Stress-induced and alcohol cue-induced craving in recently abstinent alcohol-dependent individuals. Alcohol Clin Exp Res 31:395–403
Fox HC, Anderson GM, Tuit K, Hansen J, Kimmerling A, Siedlarz KM, Morgan PT, Sinha R (2012) Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings. Alcohol Clin Exp Res 36:351–360
Gass JT, Olive F (2007) Reinstatement of ethanol-seeking behavior following intravenous self-administration in Wistar rats. Alcohol Clin Exp Res 31:1–5
Goldberg MR, Robertson D (1983) Yohimbine: a pharmacological probe for study of the α2-adrenoceptor. Pharmacol Rev 35:143–180
Grasing K, Sturgill MG, Rosen RC, Trout JR, Thomas TJ, Kulkarni GD, Maines P, Seibold JR (1996) Effects of yohimbine on autonomic measures are determined by individual values for area under the concentration-time curve. J Clin Pharmacol 36:814–822
Greenwald MK (2002) Heroin craving and drug use in opioid-maintained volunteers: effects of methadone dose variations. Exp Clin Psychopharmacol 10:39–46
Greenwald MK (2005) Opioid craving and seeking behavior in physically dependent volunteers: effects of acute withdrawal and drug reinforcement opportunity. Exp Clin Psychopharmacol 13:3–14
Greenwald MK (2010) Effects of experimental unemployment, employment and punishment analogs on opioid seeking and consumption in heroin-dependent volunteers. Drug Alcohol Depend 111:64–73
Greenwald MK, Hursh SR (2006) Behavioral economic analysis of opioid consumption in heroin-dependent individuals. Drug Alcohol Depend 85:35–48
Greenwald MK, Johanson CE, Moody DE, Woods JH, Kilbourn MR, Koeppe RA, Schuster CR, Zubieta JK (2003) Effects of buprenorphine maintenance dose on mu-opioid receptor binding potential, plasma concentration, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology 28:2000–2009
Griffiths RR, Troisi JR, Silverman K, Mumford GK (1993) Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav Pharmacol 4:3–13
Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT (2005) Repeated psychological stress testing in stimulant-dependent patients. Prog Neuro-Psychopharmacol Biol Psychiatry 29:669–677
Jobes ML, Ghitza UE, Epstein DH, Phillips KA, Heishman SJ, Preston KL (2011) Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology (Berl) 218:83–88
Kleinknecht RA, Kleinknecht EE, Sawchuck CN, Lee T, Lohr JM (1999) Medical Fear Survey: psychometric properties. Behav Therapist 22:109–119
Koob GF (2008) A role for brain stress systems in addiction. Neuron 59:11–34
Koob GF (2010) The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res 1314:3–14
Kreek MJ, Koob GF (1998) Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51:23–47
Lê AD, Harding S, Juzytsch W, Funk D, Shaham Y (2005) Role of alpha-2 adrenoreceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology 179:366–373
Lê AD, Funk D, Juzytsch W, Coen K, Navarre BM, Cifani C, Shaham Y (2011) Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats. Psychopharmacology 218:89–99
Lee B, Teifenbacher S, Platt DM, Spealman RD (2004) Pharmacological blockade of α2-adrenoreceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology 29:686–693
Mattila M, Seppala T, Mattila MJ (1988) Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam. Int Clin Psychopharmacol 3:215–229
McEwen BS (2007) Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87:873–904
McNair D, Lorr M, Droppleman L (1971) Profile of Mood States manual. Educational and Industrial Testing Service, San Diego
Millan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas JP, Coge F, Galizzi JP, Boutin JA, Rivet JM, Dekeyne A, Gobert A (2000) Agonist and antagonist actions of yohimbine as compared to fluparoxan at a2-adrenergic receptors (ARs), serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors: significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse 35:79–95
Nesic J, Duka T (2006) Gender specific effects of a mild stressor on alcohol cue reactivity in heavy social drinkers. Pharmacol Biochem Behav 83:239–248
Nielsen CK, Simms JA, Bito-Onon JJ, Li R, Ananthan S, Bartlett SE (2012) The delta opioid receptor antagonist, SoRI-9409, decreases yohimbine stress-induced reinstatement of ethanol-seeking. Addict Biol 17:224–234
Pellow S, Johnston AL, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes and interactions with yohimbine and FG7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol 39:917–928
Rose JE, Ananda S, Jarvik ME (1983) Cigarette smoking during anxiety-provoking and monotonous tasks. Addict Behav 8:353–359
Schuster CR, Greenwald MK, Johanson CE, Heishman SJ (1995) Measurement of drug craving during naloxone-precipitated withdrawal in methadone maintained volunteers. Exp Clin Psychopharmacol 3:424–431
Shaham Y, Stewart J (1994) Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats. Psychopharmacology (Berl) 114:523–527
Shaham Y, Stewart J (1995) Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 119:334–341
Shaham Y, Alvares K, Nespor SM, Grunberg NE (1992) Effect of stress on oral morphine and fentanyl self-administration in rats. Pharmacol Biochem Behav 41:615–619
Shaham Y, Rajabi H, Stewart J (1996) Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal. J Neurosci 16:1957–1963
Shaham Y, Highfield D, Delfs J, Leung S, Stewart J (2000) Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci 12:292–302
Shepard JD, Bossert JM, Liu SY, Shaham Y (2004) The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biol Psychiatry 55:1082–1089
Sinha R, Catapano D, O'Malley S (1999) Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology (Berl) 142:343–351
Sinha R, Fuse T, Aubin LR, O'Malley SS (2000) Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl) 152:140–148
Sinha R, Kimmerling A, Doebrick C, Kosten TR (2007) Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology 190:569–574
Sinha R, Shaham Y, Heilig M (2011) Translational and reverse translational research on the role of stress in drug craving and relapse. Psychopharmacology (Berl) 218:69–82
Smith RJ, Aston-Jones G (2008) Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct 213:43–61
Söderpalm A, Blomqvist O, Söderpalm B (1995) The yohimbine-induced anticonflict effect in the rat, part I. Involvement of noradrenergic, serotonergic and benzodiazepinergic mechanisms. J Neural Transm Gen Sect 100:175–189
Stewart J (2003) Stress and relapse to drug seeking: studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability. Am J Addict 12:1–17
Stine SM, Southwick SM, Petrakis IL, Kosten TR, Charney DS, Krystal JH (2002) Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry 51:642–651
Sturgill MG, Grasing KW, Rosen RC, Thomas TJ, Kulkarni GD, Trout JR, Maines M, Seibold JR (1997) Yohimbine elimination in normal volunteers is characterized by both one- and two-compartment behavior. J Cardiovasc Pharmacol 29:697–703
Thomas SE, Bacon AK, Randall PK, Brady KY, See RE (2011) An acute psychological stressor increases drinking in non-treatment-seeking alcoholics. Psychopharmacology 218:19–28
Zachary RA (1991) Shipley Institute of Living Scale: Revised Manual. Western Psychological Services, Los Angeles
Acknowledgments
NIH grant R01 DA015462 from the National Institute on Drug Abuse and a State of Michigan grant (Joe Young, Sr. Funds) supported this research. Data for this study were obtained under registered NIH clinical trial NCT00684840. Preliminary data were presented orally at the June 2010 meeting of the College on Problems of Drug Dependence. The authors thank Dr. Carl Christensen for medical screening and monitoring; Ken Bates for recruiting participants; and Debra Kish, Joi Moore, Lisa Sulkowski, and Melissa Williams for experimental data collection and management.
Conflict of interest
The authors declare no conflict of interest with respect to the conduct or content of this work.
Disclosures
Dr. Greenwald has received compensation as a consultant to Reckitt-Benckiser Pharmaceuticals, Inc., the company that markets buprenorphine products. Both Dr. Greenwald and Dr. Steinmiller have received compensation from Titan Pharmaceuticals, Inc., which manufactures a buprenorphine product. Dr. Lundahl has received compensation from Gateway Community Health (Michigan) and the National Football League.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Greenwald, M.K., Lundahl, L.H. & Steinmiller, C.L. Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals. Psychopharmacology 225, 811–824 (2013). https://doi.org/10.1007/s00213-012-2868-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-012-2868-9